CD95 (APO-1/Fas) and Parkinson's disease - Reply

被引：0
|
作者：
Zipp, F
Martin, R
Dichgans, J
Weller, M
机构：
[1] Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany
[2] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
来源：
ANNALS OF NEUROLOGY | 1998年 / 44卷 / 03期
关键词：
D O I：
10.1002/ana.410440331
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：426 / 426
页数：1
相关论文
共 50 条
  • [1] CD95 (APO-1/Fas) and Parkinson's disease
    Hartmann, A
    Hunot, S
    Hirsch, EC
    Hirsch, C
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 425 - 425
  • [2] The CD95(APO-1/Fas) DISC and beyond
    M E Peter
    P H Krammer
    Cell Death & Differentiation, 2003, 10 : 26 - 35
  • [3] CD95(apo-1/fas) signalling and diseases
    Krammer, PH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R1 - R1
  • [4] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (01): : 26 - 35
  • [5] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [6] Characterization of Fas (Apo-1, CD95)-Fas ligand interaction
    Schneider, P
    Bodmer, JL
    Holler, N
    Mattmann, C
    Scuderi, P
    Terskikh, A
    Peitsch, MC
    Tschopp, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18827 - 18833
  • [7] CD95 (APO-1/Fas)-associating signalling proteins
    Peter, ME
    Kischkel, FC
    Hellbardt, S
    Chinnaiyan, AM
    Krammer, PH
    Dixit, VM
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 161 - 170
  • [8] Fas (CD95, Apo-1) Ligand Gene Transfer
    Salah-Eddine Lamhamedi-Cherradi
    Youhai Chen
    Journal of Clinical Immunology, 2001, 21 : 24 - 29
  • [9] FasL-Fas/APO-1(CD95)系统
    孙长凯
    鞠躬
    生理科学进展, 1997, (02) : 42 - 44
  • [10] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06): : 1675 - 1687
12345